Toward Understanding Drivers of Patient Engagement With Digital Mental Health Interventions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-07

Study Completion Date

2025-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a clinical trial that evaluates what drives patient engagement and tests the impact of two strategies-automated motivational push messaging and coach support-to improve engagement with an evidence-based mobile app intervention for depression and/or anxiety.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using Machine Learning to Optimize User Engagement and Clinical Response to Digital Mental Health Interventions

NCT05567640

Anxiety Disorders and Symptoms Depressive Symptoms

UNKNOWN NA

IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression

NCT02801877

Depression Anxiety

COMPLETED NA

Integrating a Suite of Mental Health Apps for Depression in a Healthcare Setting

NCT05274620

Depression Anxiety

COMPLETED NA

IntelliCare in College Students

NCT04035577

Depression Anxiety

COMPLETED NA

IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)

NCT02176226

Major Depressive Disorder Anxiety Disorders

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This 8-week, clinical trial involves primary care patients with clinically significant depression and/or anxiety recruited via provider referral. Participants will received access to a digital mental health intervention with known efficacy and be randomized to an engagement strategy condition--a previously-validated Coach Support protocol (CS), a newly-developed automated motivational messaging protocol (AMM), both or neither. To further understand how messages in the AMM arms function, message delivery will be micro-randomized: each day participants will be randomized to receive a message or not, such that they receive an average of 4.2 messages/week. Micro-randomization allows causal inference about the near-term impact of message delivery (i.e., are AMMs a cue to action) and the relationship between message impact and context (e.g., day in study). Measured outcome data will include level of engagement (operationalized as minutes of intervention use) and weekly self-reports of clinical outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression Anxiety Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

2x2 factorial trial with micro-randomization in automated motivational messaging arms

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IntelliCare with Automated Motivational Messaging and Coach Support

IntelliCare Plus mobile application intervention with two engagement strategies, automated motivational messaging and coach support.

Group Type EXPERIMENTAL